Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Onco-Innovations files prospectus in four Canadian provinces to potentially raise capital for oncology research, pending regulatory approval.

flag Onco-Innovations Limited has filed a preliminary base shelf prospectus in four Canadian provinces, dated February 3, 2026, to potentially offer securities like common shares, debt, and warrants over 25 months. flag The move aims to provide financial flexibility, but no sales will occur until regulators issue final approval and supplements are filed. flag The company, focused on oncology and solid tumor treatments, notes no commitments exist for specific offerings, and U.S. securities laws do not apply. flag Forward-looking statements carry risks, and actual results may differ. flag More details are available on SEDAR+.

6 Articles